Skip to main content Skip to main navigation menu Skip to site footer

Chronic limb-threatening ischemia Rutherford VI, successful infra inguinal stenting: a case report

  • Putri Oktaviani Zulfa ,
  • Yopie Afriandi Habibie ,


Abstract

Introduction: Chronic limb-threatening ischemia (CLTI) is a remarkably morbid condition that causes significant mortality, limb loss, pain, as well as reduce health-related quality of life in those who are affected. The cornerstone of CLTI therapy is revascularization, which can lower the amputation rate.

Case description:  A diabetic type II 68-year-old female patient presented with complaints of pain, swelling, and itching in the left leg that was felt for approximately 1 month ago. The wound persists although the ankle was already amputated. CT-angiography showed total occlusion in 1/3 distal of left femoral artery and no visualization of left popliteal artery. She was diagnosed as left CLTI femoral popliteal Rutherford VI TASC II type D with ischemic rest pain. The patient planned for an endovascular revascularization procedure. Victory 14 wire 0.014” was inserted but recanalization did not penetrate, continued with Victory 18 wire the lesion could penetrate. Digital Subtract Angiography (DSA) evaluation found significant residual stenosis, thus continued using Abbott Supera peripheral stent system. The patient was successfully treated showed left femoral artery was seen well visualized with TIMI flow 3, left popliteal artery was still seen 50% no significant residual stenosis with TIMI flow 2. Followed up after 3 months, she did not complain any ischemic pain at left leg.

Discussion: The Supera peripheral stent system was developed to withstand the femoropopliteal artery's unique stressors. There have been few studies on the use of supera stenting in complex CLTI, and the primary patency at 1 year was 77% in lesions measuring 92-236 mm. In this case report, the procedure was successfully applied in complex CLTI (mean length >200mm) with no restenosis and repeat target limb revascularization after one year of procedure.

Conclusion: We successfully performed revascularization using supera stenting, and the femoropopliteal artery showed good TIMI flow results. In CLTI patients, stenting may be an option to lower the risk of major lower limb amputation.

Keywords: limb ischemia artery management percutaneous

References

  1. Habibie YA, Abidin Z. Chronic Limb-Threatening Ischemia: Current Perspective. Adv Clin Med Res. 2020;1(1):1. Available from: http://dx.doi.org/10.52793/acmr.2020.1(1)-03.
  2. Anhar A, Habibie YA. Revascularization limb salvage in chronic limb-threatening ischemia: does open surgery still the best option in the era of endovascular therapy? Intisari Sains Medis. 2020;11(1):369. Available from: http://dx.doi.org/10.15562/ism.v11i1.745
  3. Jones WS, Hiatt WR, Patel MR. Response by Jones et al to Letter Regarding Article, “Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.” Circulation. 2017;135(23). Available from: http://dx.doi.org/10.1161/circulationaha.117.028199
  4. Farber A. Chronic Limb-Threatening Ischemia. N Engl J Med. 2018;379(2):171–80. Available from: http://dx.doi.org/10.1056/nejmcp1709326
  5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(1):S5–67. Available from: http://dx.doi.org/10.1016/j.jvs.2006.12.037
  6. Arain SA, White CJ. Endovascular therapy for critical limb ischemia. Vasc Med. 2008;13(3):267–79. Available from: http://dx.doi.org/10.1177/1358863x07087129
  7. Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6):126S-136S. Available from: http://dx.doi.org/10.1016/j.jvs.2018.01.071
  8. Hirsch et al. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary. Circulation. 2006;113(11):1474–547. Available from: http://dx.doi.org/10.1161/circulationaha.106.173994
  9. Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R. Critical limb ischemia: current challenges and future prospects. Vasc Health Risk Manag. 2018;14:63–74. Available from: https://pubmed.ncbi.nlm.nih.gov/29731636
  10. Goodney PP, Travis LL, Nallamothu BK, Holman K, Suckow B, Henke PK, et al. Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes. 2011/12/06. 2012;5(1):94–102. Available from: https://pubmed.ncbi.nlm.nih.gov/22147886
  11. Gerhard-Herman et al. Correction to: 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12). Available from: http://dx.doi.org/10.1161/cir.0000000000000501
  12. Suresh K. Global vascular guidelines on the management of chronic limb-threatening ischemia: A brief purview. Indian J Vasc Endovasc Surg. 2019;6(3):147. Available from: http://dx.doi.org/10.4103/ijves.ijves_50_19
  13. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, et al. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Vasc Med. 2015;20(5):465–78. Available from: http://dx.doi.org/10.1177/1358863x15597877
  14. Domínguez LJG, Moreno IR, Núñez LG, Hernández MM. Hybrid revascularization of chronic limb-threatening ischemia using popliteal below-knee and tibial trifurcation open endarterectomy distally plus inter-woven nitinol stenting proximally. Ann Vasc Surg. 2022;80:386–91. Available from: http://dx.doi.org/10.1016/j.avsg.2021.10.056
  15. Bishu K, Armstrong EJ. Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence. Vasc Health Risk Manag. 2015;11:387–95. Available from: https://pubmed.ncbi.nlm.nih.gov/26203255
  16. Guzzardi G, Spinazzola A, Cangiano G, Natrella M, Paladini A, Porta C, et al. Endovascular treatment of femoro-popliteal disease with the Supera stent: results of a multicenter study. J Public health Res. 2021;11(1):2360. Available from: https://pubmed.ncbi.nlm.nih.gov/34595901

How to Cite

Zulfa, P. O. ., & Habibie, Y. A. (2022). Chronic limb-threatening ischemia Rutherford VI, successful infra inguinal stenting: a case report. Bali Medical Journal, 12(2), 1622–1624. https://doi.org/10.15562/bmj.v12i2.3962
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
13

Total
8

Share

Search Panel

Putri Oktaviani Zulfa
Google Scholar
Pubmed
BMJ Journal

Yopie Afriandi Habibie
Google Scholar
Pubmed
BMJ Journal